Published in Gynecol Oncol on November 22, 2011
Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer Biol Ther (2012) 0.99
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness. Oncogene (2014) 0.93
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation. Exp Cell Res (2013) 0.90
Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells. J Cancer (2015) 0.80
Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase. Cancer Sci (2015) 0.80
Beyond Telomerase: Telomere Instability as a Novel Target for Cancer Therapy. J Mol Genet Med (2013) 0.75
The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review. Geburtshilfe Frauenheilkd (2016) 0.75
MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer. PLoS One (2017) 0.75
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics (2008) 3.11
Inactivation of specific β cell transcription factors in type 2 diabetes. J Clin Invest (2013) 2.18
Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem (2003) 1.98
A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol (2006) 1.77
Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol (2008) 1.54
Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol (2005) 1.45
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat (2007) 1.41
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol Cancer (2007) 1.40
Is N-cadherin expression important in ductal carcinoma? South Med J (2008) 1.37
The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J Biol Chem (2009) 1.36
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochem Biophys Res Commun (2006) 1.33
The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma. Gynecol Oncol (2006) 1.31
Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer (2009) 1.25
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res (2008) 1.24
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol Oncol (2007) 1.23
Emerging role of nuclear protein 1 (NUPR1) in cancer biology. Cancer Metastasis Rev (2009) 1.23
A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin Exp Metastasis (2004) 1.23
Recent advances in anti-angiogenic therapy of cancer. Oncotarget (2011) 1.22
CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin Exp Metastasis (2012) 1.18
Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J Proteome Res (2007) 1.14
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress. Curr Cancer Drug Targets (2008) 1.11
Multi-faceted role of HSP40 in cancer. Clin Exp Metastasis (2009) 1.11
Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clin Exp Metastasis (2008) 1.10
Gene therapy for ovarian cancer. Curr Oncol Rep (2006) 1.08
Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett (2005) 1.06
Dickkopf1: a tumor suppressor or metastasis promoter? Int J Cancer (2011) 1.03
Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis. J Biol Chem (2010) 1.01
Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation. Biochemistry (2006) 1.01
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol (2007) 1.00
Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer. Biochim Biophys Acta (2008) 0.99
A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of pelvic masses. Gynecol Oncol (2005) 0.98
The effect of obesity on survival in patients with ovarian cancer. Gynecol Oncol (2008) 0.98
Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation. J Biol Chem (2011) 0.97
Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition. J Biol Chem (2013) 0.95
Rac1 activity regulates proliferation of aggressive metastatic melanoma. Exp Cell Res (2007) 0.95
Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report. Gynecol Oncol (2005) 0.94
Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. Int J Oncol (2011) 0.94
Hedgehog signaling: networking to nurture a promalignant tumor microenvironment. Mol Cancer Res (2011) 0.94
Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). Int J Cancer (2002) 0.93
DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype. J Biol Chem (2010) 0.93
The hedgehog pathway conditions the bone microenvironment for osteolytic metastasis of breast cancer. Int J Breast Cancer (2011) 0.91
Diagnostic loop electrosurgical excisional procedure for discrepancy: do preoperative factors predict presence of significant cervical intraepithelial neoplasia? J Low Genit Tract Dis (2007) 0.90
microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer. Mol Cancer (2014) 0.90
Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases. PLoS One (2012) 0.89
Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes. Obstet Gynecol (2006) 0.89
A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Clin Cancer Res (2007) 0.87
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology (2010) 0.87
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance. FEBS Lett (2012) 0.87
The incidence and clinical significance of lymph node micrometastases determined by immunohistochemical staining in stage I - lymph node negative endometrial cancer. Histol Histopathol (2012) 0.87
Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer. Mol Cancer (2010) 0.87
Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy. J Am Coll Surg (2006) 0.86
Overcoming technical challenges with robotic surgery in gynecologic oncology. Surg Endosc (2009) 0.86
Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. Cancer Biol Ther (2005) 0.86
Complete uterine necrosis following chemoradiation for advanced cervical cancer: a case report. Gynecol Oncol (2007) 0.84
DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity. Biochem J (2012) 0.83
Merlin: the wizard requires protein stability to function as a tumor suppressor. Biochim Biophys Acta (2012) 0.82
Micro-RNA-632 downregulates DNAJB6 in breast cancer. Lab Invest (2012) 0.81
The influence of the cancer microenvironment on the process of metastasis. Int J Breast Cancer (2012) 0.81
Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy: does preoperative anticoagulation matter? Int J Gynecol Cancer (2011) 0.81
Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy. Int J Gynecol Cancer (2009) 0.81
Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer. Int J Cancer (2007) 0.80
Cellular stress stimulates nuclear localization signal (NLS) independent nuclear transport of MRJ. Exp Cell Res (2012) 0.79
A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia. J Low Genit Tract Dis (2004) 0.78
A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer. Gynecol Oncol (2007) 0.77
Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis (2013) 0.76
Recurrence of endometrial adenocarcinoma in a prior Bartholin's cyst marsupialization incision. Gynecol Oncol (2006) 0.76
Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies. Gynecol Oncol (2006) 0.75
Signs of aging or the vague symptoms of ovarian cancer? Oncol Nurs Forum (2012) 0.75
Unilateral cervical cancer in a patient with cervix duplex. Gynecol Oncol (2006) 0.75
Bilateral femoral neck fractures associated with complex pelvic ring injuries in a pediatric patient: a case report. J Pediatr Orthop B (2017) 0.75